News

IHI Call Days

The Innovative Health Initiative (IHI) Program Office just pre-published the call for proposals on “Establishing novel approaches to improve clinical trials for rare and ultra-rare diseases”. Check out additional details at the following link: https://www.ihi.europa.eu/sites/default/files/uploads/Documents/Calls/FutureTopics/DraftTopic_TrialsRareDiseases_June2023.pdf Don’t miss out the recording from the information webinar: here. The topics will be formally published at the end of July […]

Read More

IRDiRC announces change in leadership for its Funders Constituent Committee (FCC)

The International Rare Diseases Research Consortium (IRDiRC) announces new leadership changes in its Funders Constituent Committee (FCC). Dr. Adam Hartman (Program Director at the National Institute of Neurological Disorders and Stroke (NINDS), USA), FCC Chair, and Dr. Catherine Nguyen (Director at the Thematic Institute of Genetics, Genomics, and Bioinformatics, INSERM, France), FCC Vice Chair, have […]

Read More

WHO Call for Experts – Technical Advisory Group on Genomics

This call builds on World Health Organization’s enduring efforts in the field of Genomics and follows the publication of the Report “Accelerating access to genomics for global health: promotion, implementation, collaboration, and ethical, legal and social issues” by the WHO Science Council in 2022.  The WHO is now seeking to establish a Technical Advisory Group […]

Read More

IHI Announces Considered Topics for Upcoming Calls for Proposals + Related event (IHI Call Days)

The Innovative Health Initiative (IHI) has revealed the potential topics for inclusion in their upcoming calls for proposals. With the aim of enabling potential applicants to begin preparations, IHI has decided to publish the draft topic texts ahead of the official call launch, scheduled for summer 2023. IHI call 4 (two-stage call) Expanding translational knowledge […]

Read More

Join IRDiRC Therapies Scientific Committee!

The Therapies Scientific Committee (TSC) would like to broaden the committee membership, to represent the worldwide rare disease therapies community in its full width, from early innovation towards regulatory approval and therapeutic support of patients. As such, the TSC has three openings for new members, specifically encouraging participants from the following regions: Africa, Asia, Australasia […]

Read More

NINDS’ Annual Nonprofit Forum

The National Institute of Neurological Disorders and Stroke (NINDS) invites members of nonprofit organizations to an annual Nonprofit Forum. The Progress through Partnership Forum provides an opportunity for nonprofit leaders to network with colleagues and to engage in discussions with NINDS staff. The Forum will take place on July 24-25, 2023. Registration and more information […]

Read More

Global Genes – Xcelerate RARE Open Science Data Challenge

Global Genes is excited to share the news that the Xcelerate RARE Open Science Data Challenge has officially opened! The Xcelerate RARE: A Rare Disease Open Science Data Challenge is bringing together researchers and data scientists in a collaborative and competitive environment to make the best use of patient-provided data to solve big unknowns in […]

Read More

Annual IMPC Conference ‘The Power of Mouse Genetics: Opportunities for Genomic and Precision Medicine’ 10-11 July in Oxford (UK)

This year the annual conference of the International Mouse Phenotyping Consortium (IMPC) will be held at Keble College, Oxford, UK from the 10-11 July, 2023. The conference is entitled: “The Power of Mouse Genetics: Opportunities for Genomic and Precision Medicine“. It features an outstanding list of distinguished speakers at the forefront of mouse and human […]

Read More

EURORDIS Open Academy: seeking advice

The EURORDIS Open Academy has launched a survey to know more about training needs, such as the reasons for engaging in training, main topics of interest, and the roadblocks that would prevent people from attending a training. The survey is open now and will be closing on 31st May, 2023. The target audience is rare […]

Read More